Literature DB >> 8134588

Necrosis in pontine gliomas: radiation induced or natural history?

M D Nelson1, D Soni, T Z Baram.   

Abstract

PURPOSE: To determine whether the central necrotic lesions that develop in a large number of patients with pontine gliomas are secondary to radiation therapy, specifically high-dose (7,200-7,800 cGy) hyperfractionation radiation therapy, or are part of the biologic progression of this tumor.
MATERIALS AND METHODS: The authors analyzed neuroimaging studies of 31 consecutive patients with pontine-centered gliomas and assessed the time of onset of necrosis, the type and dose of radiation therapy administered, and the length of survival.
RESULTS: Necrosis was present at diagnosis in eight of the 31 patients (26%). Time to appearance and total prevalence of central necrosis did not differ in the standard versus hyperfractionated therapy groups. The time between diagnosis and the appearance of necrosis correlated with length of survival (P = .005, Kendall correlation).
CONCLUSION: In a substantial number of patients, central necrosis in pontine gliomas is not caused by radiation therapy but is an indication of an advanced tumor stage. Children with central necrosis at diagnosis have a significantly shorter median survival than do those without, regardless of the type of therapy administered.

Entities:  

Mesh:

Year:  1994        PMID: 8134588     DOI: 10.1148/radiology.191.1.8134588

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.

Authors:  Nathan A Dahl; Arthur K Liu; Nicholas K Foreman; Melissa Widener; Laura Z Fenton; Margaret E Macy
Journal:  Childs Nerv Syst       Date:  2019-07-31       Impact factor: 1.475

2.  Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma.

Authors:  Emilie A Steffen-Smith; Joanna H Shih; Sean J Hipp; Robyn Bent; Katherine E Warren
Journal:  J Neurooncol       Date:  2011-05-13       Impact factor: 4.130

3.  Apparent diffusion and fractional anisotropy of diffuse intrinsic brain stem gliomas.

Authors:  H J Chen; A Panigrahy; G Dhall; J L Finlay; M D Nelson; S Blüml
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-01       Impact factor: 3.825

4.  Elevated citrate in pediatric astrocytomas with malignant progression.

Authors:  Stefan Blüml; Ashok Panigrahy; Mikhail Laskov; Girish Dhall; Mark D Krieger; Marvin D Nelson; Jonathan L Finlay; Floyd H Gilles
Journal:  Neuro Oncol       Date:  2011-07-19       Impact factor: 12.300

Review 5.  Role of MRI in the management of children with diffuse pontine tumors: a study of 15 patients and review of the literature.

Authors:  Liora Kornreich; Michael Schwarz; Boaz Karmazyn; Ian J Cohen; Avinoam Shuper; Shalom Michovitz; Issac Yaniv; Eyal Fenig; Gadi Horev
Journal:  Pediatr Radiol       Date:  2005-05-26

6.  Citrate in pediatric CNS tumors?

Authors:  Z A Seymour; A Panigrahy; J L Finlay; M D Nelson; S Blüml
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

7.  Metabolism of diffuse intrinsic brainstem gliomas in children.

Authors:  Ashok Panigrahy; Marvin D Nelson; Jonathan L Finlay; Richard Sposto; Mark D Krieger; Floyd H Gilles; Stefan Blüml
Journal:  Neuro Oncol       Date:  2007-11-14       Impact factor: 12.300

8.  Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.

Authors:  Arthur K Liu; Margaret E Macy; Nicholas K Foreman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-15       Impact factor: 7.038

9.  Treatment of paediatric pontine glioma with oral trophosphamide and etoposide.

Authors:  J E A Wolff; S Westphal; G Mölenkamp; A Gnekow; M Warmuth-Metz; D Rating; J Kuehl
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

10.  Diffusion tensor histogram analysis of pediatric diffuse intrinsic pontine glioma.

Authors:  Emilie A Steffen-Smith; Joelle E Sarlls; Carlo Pierpaoli; Joanna H Shih; Robyn S Bent; Lindsay Walker; Katherine E Warren
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.